Christian Angermayer
Founding Investor & Advisor
Christian is an entrepreneur, investor and film enthusiast. He is the founder of Apeiron Investment Group, his family office and merchant banking business. Apeiron focuses on Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate.
Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed Seed/Start Up investments to larger scale Restructuring and Special Situations deals (mostly listed). In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with US peer Alnylam in 2003 and subsequently went public.
Since then, Christian has created, co-founded and invested in numerous successful companies, has raised approx. USD 2bn for his portfolio companies and has been involved in more than 40 successful IPO- and M&A-transactions either as an entrepreneur, investor or banker/advisor. With his biotech company ATAI Life Sciences, Christian has the ambitious goal to enable people to live healthier and happier lives.
In addition to his entrepreneurial activities, Christian places great value on social, political and societal commitments. Examples of his engagement in this space are his memberships at Young Global Leader of the World Economic Forum, the Milken Institute Young Leaders Circle, The Court of the London School of Hygiene and Tropical Medicine and Global Advisory Council of the Wilson Center.